Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.
about
Respirable antisense oligonucleotides: a new drug class for respiratory diseaseGrowth hormone-dependent changes in the rat lung proteome during alveorizationApproaches to Validate and Manipulate RNA Targets with Small Molecules in CellsDesign and applications of modified oligonucleotides.Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.Oligonucleotide-based knockdown technologies: antisense versus RNA interference.The characterization of cationic fusogenic liposomes mediated antisense oligonucleotides into HeLa cells.Immune-Stimulatory Dinucleotide at the 5'-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses.RASONs: a novel antisense oligonucleotide therapeutic approach for asthma.Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotidesVariables and strategies in development of therapeutic post-transcriptional gene silencing agentsKnockdown of Nurr1 in the rat hippocampus: implications to spatial discrimination learning and memory.Host factors influencing susceptibility to HIV infection and AIDS progression.Antisense oligonucleotides in the treatment of bladder cancer.Cell-specific targeting of lipid-based carriers for ODN and DNA.Antisense-based cancer therapeutics: are we there yet?Cellular delivery and photochemical activation of antisense agents through a nucleobase caging strategy.Targeted delivery systems for oligonucleotide therapeutics.Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics.Targeting apoptosis in autoimmune hepatitis.Double-stranded RNA-binding artificial cationic oligosaccharides stabilizing siRNAs with a low N/P ratio.Evaluating the specificity of antisense oligonucleotide conjugates. A DNA array analysis.Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.Targeted reduction in expression of Trypanosoma cruzi surface glycoprotein gp90 increases parasite infectivityNovel antisense oligonucleotides containing hydroxamate linkages: targeted iron-triggered chemical nucleases.Advances in the delivery of RNA therapeutics: from concept to clinical reality.Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.Specific Increase of Protein Levels by Enhancing Translation Using Antisense Oligonucleotides Targeting Upstream Open Frames.Specific inhibition of coxsackievirus B3 translation and replication by phosphorothioate antisense oligodeoxynucleotidesIn vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides.Inhibition of human colon cancer cell growth by antisense oligodeoxynucleotides targeted at basic fibroblast growth factor.Glucose conjugation of anti-HIV-1 oligonucleotides containing unmethylated CpG motifs reduces their immunostimulatory activity.Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.Transfection of mammalian cells using block copolypeptide vesicles.Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.NMR and UV studies of 3'-S-phosphorothiolate modified DNA in a DNA : RNA hybrid dodecamer duplex; implications for antisense drug design.Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells.Oligonucleotide technologies: synthesis, production, regulations and applications. 29-30th November 2000, Hamburg, Germany.Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.
P2860
Q24791659-61E857DB-D86A-482B-AF94-779103018F87Q28581018-127D3316-D8CC-4829-95E3-51EAF0246AB8Q28833658-03272FF9-1E15-43DD-A0AD-A2C00B09DD64Q30884698-F50B7583-8614-4951-9A8B-6F192AF43F78Q33184060-0C49548E-3FDD-4399-8D0E-1162C292B881Q33193599-FFB7179C-BB45-4BF0-87AA-ABE873F613D5Q33201731-6A4B99E2-E971-4C8D-89C4-634E766D98E8Q33635971-7CF48D74-E98D-4E41-BFD2-40D40D70E81FQ34452690-DD949CA9-F058-4B6F-9099-355AEAB89781Q34879217-E03F974E-F333-4B95-A299-E8D3587E85AFQ35110219-D8DF5909-F97A-4CD1-BEBF-0D3B3C57EA88Q35612936-9E412484-7CEF-4C30-B7CE-7335F175D9D4Q35995936-DF16BEC6-1B21-4F6A-B889-F705E7E01DCCQ36040819-358901A9-2CC1-47A2-89A8-4FEE7B608876Q36272601-49F33CF4-955A-4C8F-9910-9EF8AA77CA41Q36458427-57322D7B-9F8B-4EF2-A85A-E7FA07ACE926Q37376458-C5EF2AE5-11AA-4C0B-8D8E-FC757841EF6DQ37417572-89468932-5EA6-4885-A124-B283C4A7C087Q37444136-9483CF07-58D1-4DE5-8F66-40FDC492EFE0Q37942156-808C00CC-FEA4-4DCB-935B-133C518F5FC8Q38231217-2DFE482D-912B-434D-AB07-B568F47579DBQ38289241-DA7DEF40-4DC8-4FA3-BA9D-518EB4D6D54DQ38290306-F82F9288-D091-4F62-8037-DBF7E889F136Q38300594-D895D557-BC7B-4DB5-9F99-22A4CD70DD32Q38305727-DA7F34C2-67C7-4ADB-BA6E-504495C29807Q38356964-455161EB-DEDD-4680-8D54-C10D3DAEA56EQ38706445-2E2E2DD0-9E93-413E-BA8D-4B7B9BB4D465Q38734734-7F528D33-648A-46BB-851F-010BD5A0ED16Q39390082-B4F1D1AC-3CE5-4E39-8C95-9623C46C7AD3Q39476820-384268F1-51AD-4874-9B11-CEDEB3007161Q39731474-2844975A-B1EC-4E64-99C3-5ECFD5D6C378Q40779601-E5EDAB0B-7559-4BC0-ADC1-996FCC542C16Q41482402-792FA07D-E575-4738-8447-772CEC7A2948Q43207019-41EAD6F8-9734-4CCA-9D10-F88914172CF2Q44174512-1881BB82-FA90-4383-B1A4-FAC13C885762Q44471855-D2941F9A-3FC0-4D6B-B729-CA62B540AA72Q44737925-A0114000-42D4-42A1-9C0D-2980F6E9F3FDQ44960581-E2A76C7B-867E-4FAA-A2DC-8C7F144AA218Q45002635-7160A80B-72BE-4A32-A2F8-4307A8E4E1BAQ48263612-3B2DEE32-ED03-49A1-9B9D-85C5AA054C1C
P2860
Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Importance of nucleotide seque ...... of antisense oligonucleotides.
@ast
Importance of nucleotide seque ...... of antisense oligonucleotides.
@en
type
label
Importance of nucleotide seque ...... of antisense oligonucleotides.
@ast
Importance of nucleotide seque ...... of antisense oligonucleotides.
@en
prefLabel
Importance of nucleotide seque ...... of antisense oligonucleotides.
@ast
Importance of nucleotide seque ...... of antisense oligonucleotides.
@en
P1476
Importance of nucleotide seque ...... of antisense oligonucleotides.
@en
P2093
P356
10.1016/S0167-4781(99)00141-4
P407
P577
1999-12-01T00:00:00Z